Characterization of dopaminergic dysfunction in familial progressive supranuclear palsy: an ¹⁸F-dopa PET study

By Tai Y. F.   Ahsan R. L.   de Yébenes J. G.   Pavese N.   Brooks D. J.   Piccini P.  

Journal of Neural Transmission, Vol. 114, Iss. 3, 2007-03 ,pp. : 337-340

Springer Publishing Company

Access to resources Recommend Favorite

Striatal and extrastriatal dysfunction in Parkinson’s disease with dementia: a 6-[ 18 F]fluoro-l-dopa PET study

By Kachi T.  

Brain, Vol. 125, Iss. 6, 2002-06 ,pp. : 1358-1365

Oxford University Press

Access to resources Recommend Favorite

Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [ 18 F]dopa-PET study

By Rakshi J. S.   Uema T.   Ito K.   Bailey D. L.   Morrish P. K.   Ashburner J.   Dagher A.   Jenkins I. H.   Friston K. J.  

Brain, Vol. 122, Iss. 9, 1999-09 ,pp. : 1637-1650

Oxford University Press

Access to resources Recommend Favorite

Longitudinal Behavioral and 6-[ 18 F]Fluoro-l-DOPA-PET Assessment in MPTP-Hemiparkinsonian Monkeys

By Melega W.P.   Raleigh M.J.   Stout D.B.   DeSalles A.A.   Cherry S.R.   Blurton-Jones M.   Morton G.G.   Huang S.-C.   Phelps M.E.  

Experimental Neurology, Vol. 141, Iss. 2, 1996-10 ,pp. : 318-329

Elsevier

Access to resources Recommend Favorite

Clinical utility of flumazenil-PET versus [ 18 F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients

By Ryvlin P   Bouvard S   Le Bars De   De Lamérie G   Grégoire MC   Kahane P   Froment JC   Mauguiére F  

Brain, Vol. 121, Iss. 11, 1998-11 ,pp. : 2067-2081

Oxford University Press

Access to resources Recommend Favorite